Presentation THT 2023 MIRTH: Myocardial Intramural Remodeling by Transvenous Tether Presenter: Adam Greenbaum March 21, 2023
Presentation THT 2023 Biological vs Physical Reverse Remodeling: Implications for Device-Based Therapies for HFrEF Presenter: Michael Brener March 21, 2023
Presentation THT 2023 Vsling, A Left Ventricular Transcatheter Repair Device for HFrEF Patients Presenter: Boaz Manash March 21, 2023
News Conference News THT 2023 PCI’s Role for Patients With HFrEF and Extensive CAD: Experts Debate Todd Neale March 20, 2023
Presentation THT 2023 The PRELIEVE trial: Final 1-year outcomes of the prospective Atrial Flow Regulator study in HFrEF and HFpEF patients and post-hoc responder analysis Presenter: Christina Paitazoglou March 20, 2023
News Conference News ACC 2023 IMPLEMENT-HF: ‘Virtual’ Stewardship May Help Optimize GDMT in HFrEF L.A. McKeown March 14, 2023
News Conference News ACC 2023 How Dapagliflozin Works in HFpEF: Some Clues From CAMEO-DAPA Todd Neale March 09, 2023
News Conference News ACC 2023 BETTER CARE-HF: Embedded EHR Alert Boosts MRA Prescribing in HFrEF L.A. McKeown March 06, 2023
News Daily News Cardiac Biomarkers May Help Refine HF Risk Stratification, Progression L.A. McKeown February 17, 2023
News Daily News Vast Majority of HFrEF Patients Eligible for Vericiguat L.A. McKeown February 08, 2023
News Daily News Angioedema Risk No Higher With ARNI Than With ACE Inhibitors, ARBs Todd Neale January 23, 2023
News Daily News HFrEF’s Financial Burden May Get Relief From Inflation Reduction Act L.A. McKeown January 13, 2023
News Daily News FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil Michael O'Riordan December 14, 2022
News Daily News Sequencing HF Meds? Most Doctors Stick to Old Habits, Survey Says Todd Neale December 08, 2022